Featured Research

from universities, journals, and other organizations

Individualized Medicine Emerging From Gene-Environment Studies

Date:
January 24, 2005
Source:
Penn State
Summary:
New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.

University Park, Pa. -- New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.

"Technology has given us the ability to make a much more comprehensive picture of health outcomes," says Keith Whitfield, associate professor of biobehavioral health. "We now see, for example, that the origins of racial health disparities can involve both genes and environment and the interactions between them. The crux of the matter is the individual, with her or his unique genetic constitution and history of environmental influences."

Whitfield and Gerald McClearn, Evan Pugh professor of health and human development, are the authors of a paper, "Genes, Environment, and Race," published in the current issue of American Psychologist. The January issue is a special issue devoted to race in health and social science research.

The researchers write, "Investigations of the origins of health disparities across ethnic groups have traditionally emphasized environmental hypotheses that concentrate on social and economic inequities related to differential health outcomes. The recent explosion of genetic research clearly shows how genes affect individual variation in many aspects of health and illness."

They point out that some diseases, such as phenylketonuria or Huntington's chorea, have been found to be associated with a single major gene. However, they note, that one gene/one disease scenarios are typically not the case. Rather, because of gene/gene and gene/environment interactions, a particular genetic input or particular environmental input may have quite different consequences in different individuals. In addition, although one gene might be regarded as "the" gene for a condition, it is not necessarily "the only" gene for the condition.

In addition, Whitfield and McClearn offer the case of African American high blood pressure as an example of how the relative inputs of genetics and the environment to a disease state can vary across cultures. High blood pressure affects about 65 percent of African American elders between the ages of 65 and 74. When the Penn State researchers analyzed data from a recent twin study, the Carolina African American Twin Study of Aging, they found a large proportion of the individual variability in blood pressure for African American adults arose from environmental sources. Previous studies on other populations had shown that, although environment does impact blood pressure, genetic factors played a larger role in determining the individual differences in blood pressure.

In addition, they note that population differences can and do exist with respect not only between majority and minority populations but also among groups of different European origin. As an example, they describe research conducted by McClearn, Whitfield and colleagues with Swedish and Russian twins that showed that the proportion of variance for one particular condition attributable to genetic factors was greater for the Swedish than for the Russian sample. In addition, shared environmental influences were not important in the Swedish sample but accounted for nearly half of the variance in the Russian sample.

Whitfield notes that thanks to progress in genetics, the focus in medicine may return to treating each person as a unique individual. He says, "When doctors knew you and your family and your work and home environment, they were able to treat and prescribe for you based on their awareness of those unique characteristics. Advances in genetics can help return to a more individualized approach to medicine."


Story Source:

The above story is based on materials provided by Penn State. Note: Materials may be edited for content and length.


Cite This Page:

Penn State. "Individualized Medicine Emerging From Gene-Environment Studies." ScienceDaily. ScienceDaily, 24 January 2005. <www.sciencedaily.com/releases/2005/01/050123213425.htm>.
Penn State. (2005, January 24). Individualized Medicine Emerging From Gene-Environment Studies. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/01/050123213425.htm
Penn State. "Individualized Medicine Emerging From Gene-Environment Studies." ScienceDaily. www.sciencedaily.com/releases/2005/01/050123213425.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins